Sarepta Therapeutics Overview
Sarepta Therapeutics Discounted Cash Flow
DCF Analysis for SRPT.
Get informed when a big investor buys or sells
+ FollowFair Value
$153.22
Current Fair Value
$153.22
↑ 871.6% Upside
Undervalued by 871.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison